Named as a key player in 99 of our reports, across 33 regions and countries.
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Artificial Skin | Pharmaceuticals | $2.5 Bn | 5.8% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
Named as key players in the same markets as Mylan N.V. (number of shared markets).
AstraZeneca2 shared markets
Johnson & Johnson2 shared markets
Novartis AG2 shared markets
Sanofi2 shared markets
Sun Pharmaceutical Industries Ltd.2 shared markets
Teva Pharmaceutical Industries Ltd.2 shared markets
Abbott1 shared market
AbbVie Inc.1 shared market